Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

CD4+ and CD8+ T-cell immunity to Dengue - lessons for the study of Zika virus.

Rivino L, Lim MQ.

Immunology. 2017 Feb;150(2):146-154. doi: 10.1111/imm.12681. Review.

PMID:
27763656
2.

Human T cell responses to Japanese encephalitis virus in health and disease.

Turtle L, Bali T, Buxton G, Chib S, Chan S, Soni M, Hussain M, Isenman H, Fadnis P, Venkataswamy MM, Satishkumar V, Lewthwaite P, Kurioka A, Krishna S, Shankar MV, Ahmed R, Begum A, Ravi V, Desai A, Yoksan S, Fernandez S, Willberg CB, Kloverpris HN, Conlon C, Klenerman P, Satchidanandam V, Solomon T.

J Exp Med. 2016 Jun 27;213(7):1331-52. doi: 10.1084/jem.20151517.

3.

CD8+ T lymphocyte expansion, proliferation and activation in dengue fever.

de Matos AM, Carvalho KI, Rosa DS, Villas-Boas LS, da Silva WC, Rodrigues CL, Oliveira OM, Levi JE, Ara├║jo ES, Pannuti CS, Luna EJ, Kallas EG.

PLoS Negl Trop Dis. 2015 Feb 12;9(2):e0003520. doi: 10.1371/journal.pntd.0003520.

4.

Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.

Weiskopf D, Angelo MA, Sidney J, Peters B, Shresta S, Sette A.

J Virol. 2014 Oct;88(19):11383-94. doi: 10.1128/JVI.01108-14.

5.

Immunopathogenesis Versus Protection in Dengue Virus Infections.

Rothman AL, Medin CL, Friberg H, Currier JR.

Curr Trop Med Rep. 2014 Mar 1;1(1):13-20.

6.

Dengue virus-infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes.

Piazza P, Campbell D, Marques E, Hildebrand WH, Buchli R, Mailliard R, Rinaldo CR.

Clin Exp Immunol. 2014 Sep;177(3):696-702. doi: 10.1111/cei.12373.

7.

Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Mathew A, Townsley E, Ennis FA.

Future Microbiol. 2014;9(3):411-25. doi: 10.2217/fmb.13.171. Review.

8.

Vascular events in viral hemorrhagic fevers: a comparative study of dengue and hantaviruses.

Srikiatkhachorn A, Spiropoulou CF.

Cell Tissue Res. 2014 Mar;355(3):621-33. doi: 10.1007/s00441-014-1841-9. Review.

9.

Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.

Townsley E, Woda M, Thomas SJ, Kalayanarooj S, Gibbons RV, Nisalak A, Srikiatkhachorn A, Green S, Stephens HA, Rothman AL, Mathew A.

Immunology. 2014 Jan;141(1):27-38. doi: 10.1111/imm.12161.

10.

Cross-reactivity of T cells and its role in the immune system.

Petrova G, Ferrante A, Gorski J.

Crit Rev Immunol. 2012;32(4):349-72. Review.

11.

Sculpting humoral immunity through dengue vaccination to enhance protective immunity.

Crill WD, Hughes HR, Trainor NB, Davis BS, Whitney MT, Chang GJ.

Front Immunol. 2012 Nov 8;3:334. doi: 10.3389/fimmu.2012.00334.

12.

HLA-A*0201-restricted CD8+ T-cell epitopes identified in dengue viruses.

Duan ZL, Li Q, Wang ZB, Xia KD, Guo JL, Liu WQ, Wen JS.

Virol J. 2012 Nov 5;9:259. doi: 10.1186/1743-422X-9-259.

13.

Primary vaccination with low dose live dengue 1 virus generates a proinflammatory, multifunctional T cell response in humans.

Lindow JC, Borochoff-Porte N, Durbin AP, Whitehead SS, Fimlaid KA, Bunn JY, Kirkpatrick BD.

PLoS Negl Trop Dis. 2012;6(7):e1742. doi: 10.1371/journal.pntd.0001742.

14.

Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans.

Friberg H, Bashyam H, Toyosaki-Maeda T, Potts JA, Greenough T, Kalayanarooj S, Gibbons RV, Nisalak A, Srikiatkhachorn A, Green S, Stephens HA, Rothman AL, Mathew A.

Sci Rep. 2011;1:51. doi: 10.1038/srep00051.

16.

The necessity and quandaries of dengue vaccine development.

Thomas SJ.

J Infect Dis. 2011 Feb 1;203(3):299-303. doi: 10.1093/infdis/jiq060. No abstract available.

Items per page

Supplemental Content

Support Center